Common use of Licenses or Permits Clause in Contracts

Licenses or Permits. The Company and each of its subsidiaries possess all licenses, certificates, authorizations and permits issued by, and have made all declarations and filings with, the appropriate local, state, federal or foreign governmental or regulatory agencies or bodies (including, without limitation, those administered by the FDA or by any foreign, federal, state or local governmental or regulatory authority performing functions similar to those performed by the FDA) that are necessary for the lease of their respective properties or the conduct of their respective businesses as described in the Registration Statement and the Prospectus (collectively, the “Governmental Permits”) except where any failures to possess or make the same would not, singly or in the aggregate, reasonably be expected to have a Material Adverse Effect. The Company and its subsidiaries are in compliance with all such Governmental Permits, except where noncompliance would not reasonably be expected to have a Material Adverse Effect, and all such Governmental Permits are valid and in full force and effect, except where the invalidity or failure to be in full force and effect would not, singly or in the aggregate, reasonably be expected to have a Material Adverse Effect. Neither the Company nor any subsidiary has received written, and to the Company’s knowledge, oral, notification of any revocation, modification, suspension, termination or invalidation (or proceedings related thereto) of any such Governmental Permit and the Company has no reason to believe that any such Governmental Permit will not be renewed, except for such revocations, modifications, suspensions, terminations or invalidations which would not, singly or in the aggregate, reasonably be expected to have a Material Adverse Effect.

Appears in 3 contracts

Samples: Common Stock Sales Agreement (Avidity Biosciences, Inc.), Sales Agreement (Avidity Biosciences, Inc.), Sales Agreement (Avidity Biosciences, Inc.)

AutoNDA by SimpleDocs

Licenses or Permits. The Company and each of its subsidiaries possess all licenses, certificates, authorizations and permits issued by, and have made all declarations and filings with, the appropriate local, state, federal or foreign governmental or regulatory agencies or bodies (including, without limitation, those administered by the FDA or by any foreign, federal, state or local governmental or regulatory authority performing functions similar to those performed by the FDAFDA or otherwise governing public health, consumer safety, and consumer products) that are necessary for the ownership or lease of their respective properties or the conduct of their respective businesses as described in the Registration Statement General Disclosure Package and the Prospectus (collectively, the “Governmental Permits”) except where any failures to possess or make the same would not, singly singularly or in the aggregate, reasonably be expected to have a Material Adverse Effect. The Company and its subsidiaries are in compliance with all such Governmental Permits, except where noncompliance would not reasonably be expected to have a Material Adverse Effect, and all such Governmental Permits are valid and in full force and effect, except where the invalidity failure to be in compliance or the validity or failure to be in full force and effect would not, singly singularly or in the aggregate, reasonably be expected to have a Material Adverse Effect. Neither the Company nor any subsidiary has received written, and to the Company’s knowledge, oral, notification of any revocation, modification, suspension, termination or invalidation (or proceedings related thereto) of any such material Governmental Permit and the Company has no reason to believe that any such material Governmental Permit will not be renewed, except for such revocations, modifications, suspensions, terminations or invalidations which would not, singly or in the aggregate, reasonably be expected to have a Material Adverse Effect.

Appears in 3 contracts

Samples: Underwriting Agreement (Greenlane Holdings, Inc.), Underwriting Agreement (Greenlane Holdings, Inc.), Underwriting Agreement

Licenses or Permits. The Company and each of its subsidiaries possess possesses all licenses, certificates, authorizations and permits issued by, and have made all declarations and filings with, the appropriate local, state, federal or foreign governmental or regulatory agencies or bodies (including, without limitation, those administered by the FDA or by any foreign, federal, state or local governmental or regulatory authority performing functions similar to those performed by the FDA, but excluding Regulatory Authorizations (as defined below)) that are necessary for the ownership or lease of their respective its properties or the conduct of their respective businesses its business as described in the Registration Statement General Disclosure Package and the Prospectus (collectively, the “Governmental Permits”) except where any failures to possess or make the same would not, singly singularly or in the aggregate, reasonably be expected to have a Material Adverse Effect. The Company and its subsidiaries are is in compliance with all such Governmental Permits, except where noncompliance would not reasonably be expected to have a Material Adverse Effect, and ; all such Governmental Permits are valid and in full force and effect, except where the invalidity or failure to be in full force and effect would not, singly or in the aggregate, not reasonably be expected to have a Material Adverse Effect. Neither the The Company nor any subsidiary has not received written, and to the Company’s knowledge, oral, notification of any revocation, modification, suspension, termination or invalidation (or proceedings related thereto) of any such Governmental Permit and the Company has no reason to believe that any such Governmental Permit will not be renewed, except for where any such revocations, modifications, suspensions, terminations or invalidations which non-renewal would not, singly singularly or in the aggregate, reasonably be expected to have a Material Adverse Effect.

Appears in 3 contracts

Samples: Underwriting Agreement (Nkarta, Inc.), Underwriting Agreement (Nkarta, Inc.), Underwriting Agreement (Nkarta, Inc.)

Licenses or Permits. The Company and each of its subsidiaries possess all licenses, certificates, authorizations and permits issued by, and have made all declarations and filings with, the appropriate local, state, federal or foreign governmental or regulatory agencies or bodies (including, without limitation, those administered by the FDA or by any foreign, federal, state or local governmental or regulatory authority performing functions similar to those performed by the FDA) that are necessary for the ownership or lease of their respective properties or the conduct of their respective businesses as described in the Registration Statement General Disclosure Package and the Prospectus (collectively, the “Governmental Permits”) except where any failures to possess or make the same any such Governmental Permits would not, singly singularly or in the aggregate, reasonably be expected to have a Material Adverse Effect. The Company and its subsidiaries are in compliance with all such Governmental Permits, Permits except where noncompliance any failures to comply would not reasonably be expected to not, singularly or in the aggregate, have a Material Adverse Effect, and ; all such Governmental Permits are valid and in full force and effect, except where the invalidity validity or failure to be in full force and effect would notnot reasonably be expected to, singly singularly or in the aggregate, reasonably be expected to have a Material Adverse Effect. Neither the Company nor any subsidiary has received written, and to the Company’s knowledge, oral, written notification of any revocation, modification, suspension, termination or invalidation (or proceedings related thereto) of any such Governmental Permit and the Company has no reason to believe that any such Governmental Permit will not be renewed, except for such revocations, modifications, suspensions, terminations or invalidations which would not, singly or in the aggregate, reasonably be expected to have a Material Adverse Effect.

Appears in 2 contracts

Samples: Underwriting Agreement (Protara Therapeutics, Inc.), Underwriting Agreement (Protara Therapeutics, Inc.)

Licenses or Permits. The Company and each of its subsidiaries possess possesses all required licenses, certificates, authorizations and permits issued by, and has registered as a medical device establishment with the FDA and other governmental or regulatory authorities performing functions similar to those performed by the FDA and have made all declarations and filings with, the appropriate local, state, federal or foreign governmental or regulatory agencies or bodies (including, without limitation, those administered by the FDA or by any foreign, federal, state or local governmental or regulatory authority performing functions similar to those performed by the FDA) that are necessary for the ownership or lease of their respective properties or the conduct of their respective businesses as described in the Registration Statement and the Prospectus (collectively, the “Governmental Permits”) except where any failures to possess or make the same would not, singly singularly or in the aggregate, reasonably be expected to have a Material Adverse EffectChange. The Company and its subsidiaries are in compliance with all such Governmental Permits, except where noncompliance would not reasonably be expected to have a Material Adverse Effect, including with all conditions and limitations on the commercial rights granted by such Governmental Permits; all such Governmental Permits are valid and in full force and effect, except where the invalidity or failure to be in full force and effect would not, singly singularly or in the aggregate, reasonably be expected to have a Material Adverse EffectChange. Neither the Company nor any subsidiary has received written, and to the Company’s knowledge, oral, notification of any revocation, modification, suspension, termination or invalidation (or proceedings related thereto) of any such Governmental Permit and the Company has no reason to believe that any such Governmental Permit will not be renewed, except for such revocations, modifications, suspensions, terminations or invalidations which would not, singly or in the aggregate, reasonably be expected to have a Material Adverse Effect.

Appears in 2 contracts

Samples: Common Stock Sales Agreement (Viveve Medical, Inc.), Common Stock Sales Agreement (Viveve Medical, Inc.)

Licenses or Permits. The Company and each of its subsidiaries possess all licenses, certificates, authorizations and permits issued by, and have made all declarations and filings with, the appropriate local, state, federal or foreign governmental or regulatory agencies or bodies (including, without limitation, those administered by the FDA or by any foreign, federal, state or local governmental or regulatory authority performing functions similar to those performed by the FDA) that are necessary for the ownership or lease of their respective properties or the conduct of their respective businesses as described in the Registration Statement General Disclosure Package and the Prospectus (collectively, the “Governmental Permits”) except where any failures to possess or make the same would not, singly singularly or in the aggregate, reasonably be expected to have a Material Adverse Effect. The Company and its subsidiaries are in compliance with all such Governmental Permits, except where any noncompliance would not reasonably be expected to have a Material Adverse Effect, and ; all such Governmental Permits are valid and in full force and effect, except where the invalidity validity or failure to be in full force and effect would notnot reasonably be expected to, singly singularly or in the aggregate, reasonably be expected to have a Material Adverse Effect. Neither the Company nor any subsidiary has received written, and to the Company’s knowledge, oral, notification of any revocation, modification, suspension, termination or invalidation (or proceedings related thereto) of any such Governmental Permit and the Company has no reason to believe that any such Governmental Permit will not be renewed, except for such revocations, modifications, suspensions, terminations or invalidations which would not, singly or in the aggregate, reasonably be expected to have a Material Adverse Effect.

Appears in 2 contracts

Samples: Underwriting Agreement (Atreca, Inc.), Underwriting Agreement (Atreca, Inc.)

Licenses or Permits. The Company and each of its subsidiaries possess all licenses, certificates, authorizations and permits issued by, and have made all declarations and filings with, the appropriate local, state, federal or foreign governmental or regulatory agencies or bodies (including, without limitation, those administered by the FDA or by any foreign, federal, state or local governmental or regulatory authority performing functions similar to those performed by the FDA) that are necessary for the ownership or lease of their respective properties or the conduct of their respective businesses as described now conducted or as proposed in the Registration Statement General Disclosure Package and the Prospectus to be conducted (collectively, the “Governmental Permits”) except where any failures to possess or make the same would not, singly singularly or in the aggregate, reasonably be expected to have a Material Adverse Effect. The Company and its subsidiaries are in compliance compliance, in all material respects, with all such Governmental Permits, except where noncompliance would not reasonably be expected to have a Material Adverse Effect, ; and all such Governmental Permits are valid and in full force and effect, except where the invalidity validity or failure to be in full force and effect would not, singly singularly or in the aggregate, reasonably be expected to have a Material Adverse Effect. Neither Except as set forth in the General Disclosure Package, neither the Company nor any subsidiary has received written, and to the Company’s knowledge, oral, notification of any revocation, modification, suspension, termination or invalidation (or proceedings related thereto) of any such Governmental Permit and the Company has no reason to believe that any such Governmental Permit will not be renewed, except for such revocations, modifications, suspensions, terminations or invalidations which would not, singly or in the aggregate, reasonably be expected to have a Material Adverse Effect.

Appears in 1 contract

Samples: Underwriting Agreement (Molecular Templates, Inc.)

Licenses or Permits. The Company and each of its subsidiaries possess all licenses, certificates, authorizations and permits issued by, and have made all declarations and filings with, the appropriate localfederal, provincial, state, federal municipal, local or foreign governmental or regulatory agencies or bodies (including, without limitation, those administered by the FDA Health Canada or by any foreign, federal, state provincial, state, municipal, local or local foreign governmental or regulatory authority in Canada or any other country performing functions similar to those performed by the FDAHealth Canada) that are necessary for the ownership or lease of their respective properties or the conduct of their respective businesses as described in the Registration Statement Statement, the General Disclosure Package and the Prospectus (collectively, the “Governmental Permits”) except where any failures to possess or make the same would not, singly singularly or in the aggregate, reasonably be expected to have a Material Adverse Effect. The Company and its subsidiaries are in compliance with all such Governmental Permits, except where noncompliance would not reasonably be expected to have a Material Adverse Effect, and ; all such Governmental Permits are valid and in full force and effect, except where the invalidity validity or failure to be in full force and effect would not, singly singularly or in the aggregate, reasonably be expected to have a Material Adverse Effect. Neither the Company nor any subsidiary has received written, and to the Company’s knowledge, oral, notification of any revocation, modification, suspension, termination or invalidation (or proceedings related thereto) of any such Governmental Permit and the Company has no reason to believe that any such Governmental Permit will not be renewed, except for such revocations, modifications, suspensions, terminations or invalidations which would not, singly or in the aggregate, reasonably be expected to have a Material Adverse Effect.

Appears in 1 contract

Samples: u.s. Underwriting Agreement (Tilray, Inc.)

Licenses or Permits. The Company and each of its subsidiaries possess possesses all licenses, certificates, authorizations authorizations, approvals, registrations, clearances, exemptions, and permits issued by, and have has made all declarations and filings with, the appropriate local, state, federal or foreign governmental or regulatory agencies or bodies (bodies, including, without limitation, those administered or required by the FDA or by any foreign, federal, state or local governmental or regulatory authority performing functions similar to those performed by the FDA) FDA that are necessary for the ownership or lease of their respective its properties or the conduct of their respective businesses its business as described in the Registration Statement and or the Prospectus (collectively, the “Governmental Permits”) except where any failures to possess or make the same would not, singly singularly or in the aggregate, reasonably be expected to have a Material Adverse EffectChange. The Company and its subsidiaries are is in compliance with all such Governmental Permits, except where noncompliance the failure to be in compliance would not reasonably be expected to not, singularly or in the aggregate, have a Material Adverse Effect, and Change; all such Governmental Permits are valid and in full force and effect, except where the invalidity validity or failure to be in full force and effect would not, singly singularly or in the aggregate, reasonably be expected to have a Material Adverse EffectChange. Neither the The Company nor any subsidiary has not received written, and to the Company’s knowledge, oral, written notification of any revocation, modification, suspension, termination or invalidation (or proceedings related thereto) of any such Governmental Permit and the Company has no reason to believe that any such Governmental Permit will not be renewed, except for such revocations, modifications, suspensions, terminations or invalidations which would not, singly or in the aggregate, reasonably be expected to have a Material Adverse Effect.

Appears in 1 contract

Samples: Open Market Sale Agreement (Spruce Biosciences, Inc.)

AutoNDA by SimpleDocs

Licenses or Permits. The Company and each of its subsidiaries possess all licenses, certificates, authorizations and permits issued by, and have made all declarations and filings with, the appropriate localfederal, provincial, state, federal municipal, local or foreign governmental or regulatory agencies or bodies (including, without limitation, those administered by the FDA Health Canada or by any foreign, federal, state provincial, state, municipal, local or local foreign governmental or regulatory authority in Canada or any other country performing functions similar to those performed by the FDAHealth Canada) that are necessary for the ownership or lease of their respective properties or the conduct of their respective businesses as described in the Registration Statement Statement, the General Disclosure Package and the Prospectus (collectively, the “Governmental Permits”) except where any failures to possess or make the same would not, singly singularly or in the aggregate, reasonably be expected to have an adverse effect to the business taken as a Material Adverse Effectwhole. The Company and its subsidiaries have been and are in compliance with all such Governmental Permits, except where noncompliance would not reasonably be expected to have a Material Adverse Effect, and ; all such Governmental Permits are valid and in full force and effect, except where the invalidity validity or failure to be in full force and effect would not, singly singularly or in the aggregate, reasonably be expected to have an adverse effect on the business taken as a Material Adverse Effectwhole. Neither the Company nor any subsidiary has received written, and to the Company’s knowledge, oral, notification of any revocation, modification, suspension, termination or invalidation (or proceedings related thereto) of any such Governmental Permit and the Company has no reason to believe that any such Governmental Permit will not be renewed, except for such revocations, modifications, suspensions, terminations or invalidations which would not, singly or in the aggregate, reasonably be expected to have a Material Adverse Effect.

Appears in 1 contract

Samples: Underwriting Agreement (Tilray, Inc.)

Licenses or Permits. The Company and each of its subsidiaries possess all licenses, certificates, authorizations and permits issued by, and have made all declarations and filings with, the appropriate local, state, federal or foreign governmental or regulatory agencies or bodies (including, without limitation, those administered by the FDA or by any foreign, federal, state state, local or local foreign governmental or regulatory body exercising comparable authority performing functions similar to those performed by that of the FDA) that are necessary for the ownership or lease of their respective properties or the conduct of their respective businesses as described in the Registration Statement Statement, the General Disclosure Package and the Prospectus (collectively, the “Governmental Permits”) except where any failures to possess or make the same would not, singly singularly or in the aggregate, reasonably be expected to have a Material Adverse Effect. The Company and its subsidiaries are in compliance with all such Governmental Permits, except where noncompliance the failure to be in compliance would not reasonably be expected to not, singularly or in the aggregate, have a Material Adverse Effect, ; and all such Governmental Permits are valid and in full force and effect, except where the invalidity validity or failure to be in full force and effect would not, singly singularly or in the aggregate, reasonably be expected to have a Material Adverse Effect. Neither the Company nor any subsidiary has received written, and to the Company’s knowledge, oral, written notification of any revocation, modification, suspension, termination or invalidation (or proceedings related thereto) of any such Governmental Permit and the Company has no reason to believe that any such Governmental Permit will not be renewed, except for such revocations, modifications, suspensions, terminations or invalidations which would not, singly or in the aggregate, reasonably be expected to have a Material Adverse Effect.

Appears in 1 contract

Samples: Underwriting Agreement (Jasper Therapeutics, Inc.)

Licenses or Permits. The Company and each of its subsidiaries possess possesses all licenses, certificates, authorizations authorizations, approvals, registrations, clearances, exemptions, and permits issued by, and have made all declarations and filings with, the appropriate local, state, federal or foreign governmental or regulatory agencies or bodies (bodies, including, without limitation, those administered or required by the FDA or by any foreign, federal, state or local governmental or regulatory authority performing functions similar to those performed by the FDA) FDA that are necessary for the ownership or lease of their respective its properties or the conduct of their respective businesses its business as described in the Registration Statement General Disclosure Package and the Prospectus (collectively, the “Governmental Permits”) except where any failures to possess or make the same would not, singly singularly or in the aggregate, reasonably be expected to have a Material Adverse Effect. The Company and its subsidiaries are is in compliance with all such Governmental Permits, except where noncompliance the failure to be in compliance would not reasonably be expected to not, singularly or in the aggregate, have a Material Adverse Effect, and ; all such Governmental Permits are valid and in full force and effect, except where the invalidity validity or failure to be in full force and effect would not, singly singularly or in the aggregate, reasonably be expected to have a Material Adverse Effect. Neither the The Company nor any subsidiary has not received written, and to the Company’s knowledge, oral, written notification of any revocation, modification, suspension, termination or invalidation (or proceedings related thereto) of any such Governmental Permit and the Company has no reason to believe that any such Governmental Permit will not be renewed, except for such revocations, modifications, suspensions, terminations or invalidations which would not, singly or in the aggregate, reasonably be expected to have a Material Adverse Effect.

Appears in 1 contract

Samples: Underwriting Agreement (Spruce Biosciences, Inc.)

Licenses or Permits. The Company and each of its subsidiaries possess all licenses, certificates, authorizations and permits issued by, and have made all declarations and filings with, the appropriate localfederal, provincial, state, federal municipal, local or foreign governmental or regulatory agencies or bodies (including, without limitation, those administered by the FDA Health Canada or by any foreign, federal, state provincial, state, municipal, local or local foreign governmental or regulatory authority in Canada or any other country performing functions similar to those performed by the FDAHealth Canada) that are necessary for the ownership or lease of their respective properties or the conduct of their respective businesses as described in the Registration Statement and the Prospectus (collectively, the “Governmental Permits”) except where any failures to possess or make the same would not, singly singularly or in the aggregate, reasonably be expected to have an adverse effect to the business taken as a Material Adverse Effectwhole. The Company and its subsidiaries have been and are in compliance with all such Governmental Permits, except where noncompliance would not reasonably be expected to have a Material Adverse Effect, and ; all such Governmental Permits are valid and in full force and effect, except where the invalidity validity or failure to be in full force and effect would not, singly singularly or in the aggregate, reasonably be expected to have an adverse effect on the business taken as a Material Adverse Effectwhole. Neither the Company nor any subsidiary has received written, and to the Company’s knowledge, oral, notification of any revocation, modification, suspension, termination or invalidation (or proceedings related thereto) of any such Governmental Permit and the Company has no reason to believe that any such Governmental Permit will not be renewed, except for such revocations, modifications, suspensions, terminations or invalidations which would not, singly or in the aggregate, reasonably be expected to have a Material Adverse Effect.

Appears in 1 contract

Samples: Sales Agreement (Tilray, Inc.)

Licenses or Permits. The Company and each of its subsidiaries have possessed and do possess all licenses, certificates, authorizations and permits issued by, and have made all declarations and filings with, the appropriate local, state, federal or foreign governmental or regulatory agencies or bodies (including, without limitation, those administered by the FDA or by any supranational, foreign, federal, state or local governmental or regulatory authority performing functions similar to those performed by the FDA)) that are necessary for the ownership or lease of their respective properties or the conduct of their respective businesses as described in the Registration Statement General Disclosure Package and the Prospectus (collectively, the “Governmental Permits”) except where any failures to possess or make the same would not, singly singularly or in the aggregate, reasonably be expected to have a Material Adverse Effect. The Company and its subsidiaries are in compliance with all such Governmental Permits, except where noncompliance would not reasonably be expected to have a Material Adverse Effect, and ; all such Governmental Permits are valid and in full force and effecteffect and without limitation or restriction, except where the invalidity or failure to be in full force and effect or any limitation or restriction would not, singly singularly or in the aggregate, reasonably be expected to have a Material Adverse Effect. Neither the Company nor any subsidiary has received written, and to the Company’s knowledge, oral, notification of any revocation, modification, suspension, termination termination, limitation, restriction or invalidation (or proceedings related thereto) of any such Governmental Permit and the Company has no reason to believe that any such Governmental Permit will not be renewed, except for such revocations, modifications, suspensions, terminations renewed or invalidations which would not, singly will be subject to any limitation or in the aggregate, reasonably be expected to have a Material Adverse Effectrestriction.

Appears in 1 contract

Samples: Underwriting Agreement (Maxcyte, Inc.)

Draft better contracts in just 5 minutes Get the weekly Law Insider newsletter packed with expert videos, webinars, ebooks, and more!